ReGenTree
NJ - PrincetonBiotechnology
Focus: ReGenTree is a therapeutic peptide-focused biotech company headquartered in Princeton, NJ, specializing in ophthalmology and metabolic disease indications. The company operates at the clinical-stage level with a concentrated pipeline centered on two lead programs.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About ReGenTree
AI assessmentNot HiringNo open roles listed right now. Follow ReGenTree to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Thymosin Beta 4
DiabetesClinical Trials (1)
NCT00598871A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds
Phase 2Help build intelligence for ReGenTree
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.